CXCL12 gene expression is upregulated by hypoxia and growth arrest but not by inflammatory cytokines in rheumatoid synovial fibroblasts

Cytokine

Volumn 53, Issue 2, 2011, Pages 184-190

  Santiago, Begoña ^a   Calonge, Esther ^b   Rey, Manuel J Del ^a   Gutierrez Cañas, Irene ^c   Izquierdo, Elena ^a   Usategui, Alicia ^a   Galindo, María ^a   Alcamí, José ^b   Pablos, José L ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

CXCL12; Fibroblasts; Gene expression regulation; Promoter regions; Rheumatoid arthritis

Indexed keywords

CYTOKINE; GROWTH FACTOR; LIPOPOLYSACCHARIDE; MESSENGER RNA; STROMAL CELL DERIVED FACTOR 1;

ARTICLE; CELL HYPOXIA; CONTROLLED STUDY; CXCL12 GENE; FIBROBLAST; GENE; GENE EXPRESSION REGULATION; GENE INDUCTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; INFLAMMATION; OSTEOARTHRITIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; TRANSCRIPTION REGULATION; UPREGULATION;

ARTHRITIS, RHEUMATOID; BASE SEQUENCE; CELL HYPOXIA; CELL PROLIFERATION; CHEMOKINE CXCL12; CONSENSUS SEQUENCE; FIBROBLASTS; HUMANS; INFLAMMATION MEDIATORS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RNA, MESSENGER; SYNOVIAL FLUID; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 78651105236     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2010.06.006     Document Type: Article

References (50)

1. Nagasawa T., Tachibana K., Kishimoto T. A novel CXC chemokine PBSF/SDF-1 and its receptor CXCR4: their functions in development, hematopoiesis and HIV infection. Semin. Immunol. 1998, 10:179-185.
2. Lapidot T., Dar A., Kollet O. How do stem cells find their way home?. Blood 2005, 106:1901-1910.
3. Ceradini D.J., Gurtner G.C. Homing to hypoxia: HIF-1 as a mediator of progenitor cell recruitment to injured tissue. Trends Cardiovasc. Med. 2005, 15:57-63.
4. Gonzalo J.A., Lloyd C.M., Peled A., Delaney T., Coyle A.J., Gutierrez-Ramos J.C. Critical involvement of the chemotactic axis CXCR4/stromal cell-derived factor-1 alpha in the inflammatory component of allergic airway disease. J. Immunol. 2000, 165:499-508.
5. Pablos J.L., Santiago B., Galindo M., Torres C., Brehmer M.T., Blanco F.J., et al. Synoviocyte-derived CXCL12 is displayed on endothelium and induces angiogenesis in rheumatoid arthritis. J. Immunol. 2003, 170:2147-2152.
6. Petty J.M., Sueblinvong V., Lenox C.C., Jones C.C., Cosgrove G.P., Cool C.D., et al. Pulmonary stromal-derived factor-1 expression and effect on neutrophil recruitment during acute lung injury. J. Immunol. 2007, 178:8148-8157.
7. Pablos J.L., Amara A., Bouloc A., Santiago B., Caruz A., Galindo M., et al. Stromal-cell derived factor is expressed by dendritic cells and endothelium in human skin. Am. J. Pathol. 1999, 155:1577-1586.
8. Orimo A., Gupta P.B., Sgroi D.C., Arenzana-Seisdedos F., Delaunay T., Naeem R., et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2005, 121:335-348.
9. Burger J.A., Kipps T.J. CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood 2006, 107:1761-1767.
10. Bleul C.C., Fuhlbrigge R.C., Casasnovas J.M., Aiuti A., Springer T.A. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J. Exp. Med. 1996, 184:1101-1109.
11. Vicente-Manzanares M., Montoya M.C., Mellado M., Frade J.M., del Pozo M.A., Nieto M., et al. The chemokine SDF-1alpha triggers a chemotactic response and induces cell polarization in human B lymphocytes. Eur. J. Immunol. 1998, 28:2197-2207.
12. Jo D.Y., Rafii S., Hamada T., Moore M.A. Chemotaxis of primitive hematopoietic cells in response to stromal cell-derived factor-1. J. Clin. Invest. 2000, 105:101-111.
13. Loetscher M., Geiser T., O'Reilly T., Zwahlen R., Baggiolini M., Moser B. Cloning of a human seven-transmembrane domain receptor, LESTR, that is highly expressed in leukocytes. J. Biol. Chem. 1994, 269:232-237.
14. Santiago B., Baleux F., Palao G., Gutiérrez-Cañas I., Ramírez J.C., Arenzana-Seisdedos F., et al. Arthritis Res. Ther. 2006, 8:R43.
15. Sadir R., Imberty A., Baleux F., Lortat-Jacob H. Heparan sulfate/heparin oligosaccharides protect stromal cell-derived factor-1 (SDF-1)/CXCL12 against proteolysis induced by CD26/dipeptidyl peptidase IV. J. Biol. Chem. 2004, 279:43854-43860.
16. Peled A., Grabovsky V., Habler L., Sandbank J., Arenzana-Seisdedos F., Petit I., et al. The chemokine SDF-1 stimulates integrin-mediated arrest of CD34 (+) cells on vascular endothelium under shear flow. J. Clin. Invest. 1999, 104:1199-1211.
17. García-Moruja C., Alonso-Lobo J.M., Rueda P., Torres C., González N., Bermejo M., et al. Functional characterization of SDF-1 proximal promoter. J. Mol. Biol. 2005, 348:43-62.
18. De Klerck B., Geboes L., Hatse S., Kelchtermans H., Meyvis Y., Vermeire K., et al. Pro-inflammatory properties of stromal cell-derived factor-1 (CXCL12) in collagen-induced arthritis. Arthritis Res. Ther. 2005, 7:R1208-R1220.
19. Lukacs N.W., Berlin A., Schols D., Skerlj R.T., Bridger G.J. AMD3100, a CXCR4 antagonist, attenuates allergic lung inflammation and airway hyperreactivity. Am. J. Pathol. 2002, 160:1353-1360.
20. Kim K.W., Cho M.L., Kim H.R., Ju J.H., Park M.K., Oh H.J., et al. Up-regulation of stromal cell-derived factor 1 (CXCL12) production in rheumatoid synovial fibroblasts through interactions with T lymphocytes: role of interleukin-17 and CD40L-CD40 interaction. Arthritis Rheum. 2007, 56:1076-1086.
21. Hitchon C., Wong K., Ma G., Reed J., Lyttle D., El-Gabalawy H. Hypoxia-induced production of stromal cell-derived factor 1 (CXCL12) and vascular endothelial growth factor by synovial fibroblasts. Arthritis Rheum. 2002, 46:2587-2597.
22. Amin M.A., Mansfield P.J., Pakozdi A., Campbell P.L., Ahmed S., Martínez R.J., et al. Interleukin-18 induces angiogenic factors in rheumatoid arthritis synovial tissue fibroblasts via distinct signaling pathways. Arthritis Rheum. 2007, 56:1787-1797.
23. Fedyk E.R., Jones D., Critchley H.O., Phipps R.P., Blieden T.M., Springer T.A. Expression of stromal-derived factor-1 is decreased by IL-1 and TNF and in dermal wound healing. J. Immunol. 2001, 166:5749-5754.
24. Bradfield P.F., Amft N., Vernon-Wilson E., Exley A.E., Parsonage G., Rainger G.E., et al. Rheumatoid fibroblast-like synoviocytes overexpress the chemokine stromal cell-derived factor 1 (CXCL12), which supports distinct patterns and rates of CD4+ and CD8+ T cell migration within synovial tissue. Arthritis Rheum. 2003, 48:2472-2482.
25. Iyer V.R., Eisen M.B., Ross D.T., Schuler G., Moore T., Lee J.C., et al. The transcriptional program in the response of human fibroblasts to serum. Science 1999, 283:83-87.
26. Kasperkovitz P.V., Timmer T.C., Smeets T.J., Verbeet N.L., Tak P.P., van Baarsen L.G., et al. Fibroblast-like synoviocytes derived from patients with rheumatoid arthritis show the imprint of synovial tissue heterogeneity: evidence of a link between an increased myofibroblast-like phenotype and high-inflammation synovitis. Arthritis Rheum. 2005, 52:430-441.
27. Mattey D.L., Dawes P.T., Nixon N.B., Slater H. Transforming growth factor beta 1 and interleukin 4 induced alpha smooth muscle actin expression and myofibroblast-like differentiation in human synovial fibroblasts in vitro: modulation by basic fibroblast growth factor. Ann. Rheum. Dis. 1997, 56:426-431.
28. Ceradini D.J., Kulkarni A.R., Callaghan M.J., Tepper O.M., Bastidas N., Kleinman M.E., et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat. Med. 2004, 10:858-864.
29. Distler J.H., Wenger R.H., Gassmann M., Kurowska M., Hirth A., Gay S., et al. Physiologic responses to hypoxia and implications for hypoxia-inducible factors in the pathogenesis of rheumatoid arthritis. Arthritis Rheum. 2004, 50:10-23.
30. Parsonage G., Filer A.D., Haworth O., Nash G.B., Rainger G.E., Salmon M., et al. A stromal address code defined by fibroblasts. Trends. Immunol. 2005, 26:150-156.
31. Hendrix C.W., Collier A.C., Lederman M.M., Schols D., Pollard R.B., Brown S., et al. AMD3100 HIV Study Group. Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection. J. Acquir. Immune. Defic. Syndr. 2004, 37:1253-1262.
32. Calonge E., Alonso-Lobo J.M., Escandón C., González N., Bermejo M., Santiago B., et al. C/EBP β is a mayor regulatory element driving transcriptional activation of the CXCL12 promoter. J. Mol. Biol. 2010, 396:463-472.
33. Irwin C.R., Myrillas T.T., Traynor P., Leadbetter N., Cawston T.E. The role of soluble interleukin (IL)-6 receptor in mediating the effects of IL-6 on matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 expression by gingival fibroblasts. J. Periodontol. 2002, 73:741-747.
34. Akira S., Isshiki H., Sugita T., Tanabe O., Kinoshita S., Nishio Y., et al. A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J. 1990, 9:1897-1906.
35. Ponomaryov T., Peled A., Petit I., Taichman R.S., Habler L., Sandbank J., et al. Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function. J. Clin. Invest. 2000, 106:1331-1339.
36. Bleul C.C., Schultze J.L., Springer T.A. B lymphocyte chemotaxis regulated in association with microanatomic localization, differentiation state, and B cell receptor engagement. J. Exp. Med. 1998, 187:753-762.
37. Kim K.J., Kim H.H., Kim J.H., Choi Y.H., Kim Y.H., Cheong J.H. Chemokine stromal cell-derived factor-1 induction by C/EBPbeta activation is associated with all-trans-retinoic acid-induced leukemic cell differentiation. J. Leukoc. Biol. 2007, 82:1332-1339.
38. Akira S., Isshiki H., Nakajima T., Kinoshita S., Nishio Y., Natsuka S., et al. Regulation of expression of the interleukin 6 gene: structure and function of the transcription factor NF-IL6. Ciba. Found. Symp. 1992, 167:47-62.
39. Grunewald M., Avraham I., Dor Y., Bachar-Lustig E., Itin A., Jung S., et al. VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell 2006, 124:175-189.
40. Jung Y., Wang J., Schneider A., Sun Y.X., Koh-Paige A.J., Osman N.I., et al. Regulation of SDF-1 (CXCL12) production by osteoblasts; a possible mechanism for stem cell homing. Bone 2006, 38:497-508.
41. Lee D.M., Kiener H.P., Agarwal S.K., Noss E.H., Watts G.F., Takeichi M., et al. Cadherin-11 in synovial lining formation and pathology in arthritis. Science 2007, 315:1006-1010.
42. Blades M.C., Ingegnoli F., Wheller S.K. Stromal cell-derived factor 1 (CXCL12) induces monocyte migration into human synovium transplanted onto SCID mice. Arthritis Rheum. 2002, 46:824-836.
43. García-Vicuña R., Gómez-Gaviro M.V., Domínguez-Luis M.J., Pec M.K., González-Alvaro I., Alvaro-Gracia J.M., et al. CC and CXC chemokine receptors mediate migration, proliferation, and matrix metalloproteinase production by fibroblast-like synoviocytes from rheumatoid arthritis patients. Arthritis Rheum. 2004, 50:3866-3877.
44. Wright L.M., Maloney W., Yu X., Kindle L., Collin-Osdoby P., Osdoby P. Stromal cell-derived factor-1 binding to its chemokine receptor CXCR4 on precursor cells promotes the chemotactic recruitment, development and survival of human osteoclasts. Bone 2005, 36:840-853.
45. Buckley C.D., Amft N., Bradfield P.F., Pilling D., Ross E., Arenzana-Seisdedos F., et al. Persistent induction of the chemokine receptor CXCR4 by TGF-beta 1 on synovial T cells contributes to their accumulation within the rheumatoid synovium. J. Immunol. 2000, 165:3423-3429.
46. Nanki T., Hayashida K., El-Gabalawy H.S., Suson S., Shi K., Girschick H.J., et al. Stromal cell-derived factor-1-CXC chemokine receptor 4 interactions play a central role in CD4+ T cell accumulation in rheumatoid arthritis synovium. J. Immunol. 2000, 165:6590-6598.
47. Burger J.A., Zvaifler N.J., Tsukada N., Firestein G.S., Kipps T.J. Fibroblast-like synoviocytes support B-cell pseudoemperipolesis via a stromal cell-derived factor-1- and CD106 (VCAM-1)-dependent mechanism. J. Clin. Invest. 2001, 107:305-315.
48. Abbott J.D., Huang Y., Liu D., Hickey R., Krause D.S., Giordano F.J. Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation 2004, 110:3300-3305.
49. Kryczek I., Lange A., Mottram P., Alvarez X., Cheng P., Hogan M., et al. CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers. Cancer Res. 2005, 65:465-472.
50. Del Rey M.J., Izquierdo E., Caja S., Usategui A., Santiago B., Galindo M., et al. Human inflammatory synovial fibroblasts induce enhanced myeloid cell recruitment and angiogenesis through a hypoxia-inducible transcription factor 1alpha/vascular endothelial growth factor-mediated pathway in immunodeficient mice. Arthritis Rheum. 2009, 60:2926-2934.